Personalized assessments for treating childhood OCD
Using Personalized Assessments in the Treatment of Childhood OCD
NA · Johns Hopkins University · NCT06407648
This study is testing whether using mobile technology to personalize treatment can help kids and teens with OCD feel better compared to standard therapy.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 8 Years to 17 Years |
| Sex | All |
| Sponsor | Johns Hopkins University (other) |
| Locations | 1 site (Baltimore, Maryland) |
| Trial ID | NCT06407648 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the feasibility and acceptability of using mobile health technology for personalized assessments of obsessive-compulsive disorder (OCD) symptoms in children and adolescents. It will compare the effectiveness of personalized cognitive-behavioral therapy (CBT) informed by these assessments against standard CBT for youth diagnosed with OCD. Participants will include youth aged 8-17 who meet specific diagnostic criteria and severity levels for OCD. The study seeks to improve clinical outcomes through tailored treatment approaches.
Who should consider this trial
Good fit: Ideal candidates for this study are children and adolescents aged 8-17 who have a primary diagnosis of OCD and moderate severity of symptoms.
Not a fit: Patients with psychotic disorders, bipolar disorder, autism spectrum disorders, or significant suicidal ideation may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more effective and personalized treatment options for children and adolescents suffering from OCD.
How similar studies have performed: While personalized approaches in mental health treatment are gaining traction, this specific use of mobile health technology for OCD assessments is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. be 8-17 years of age; 2. meet diagnostic criteria for a primary diagnosis of OCD on a structured clinical interview; 3. have moderate OCD severity as evidenced by a CY-BOCS total score of ≥16; 4. medication free and/or on a stable dose of medication 8 weeks prior to study participation; 5. be English speaking. Exclusion Criteria: 1. the presence of psychotic disorder, bipolar disorder, or autism spectrum disorders; 2. significant suicidal ideation that warrants medical intervention; 3. concurrent psychotherapy for OCD; 4. inability to complete scales, or attend visits.
Where this trial is running
Baltimore, Maryland
- Johns Hopkins University School of Medicine — Baltimore, Maryland, United States (RECRUITING)
Study contacts
- Principal investigator: Joseph F. McGuire, PhD — Johns Hopkins University
- Study coordinator: Alexandra Chang
- Email: coach@jhmi.edu
- Phone: 443-300-8836
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Obsessive-Compulsive Disorder, children, adolescents, exposure with response prevention, cognitive behavioral therapy, ERP, CBT